Tonix Pharmaceuticals Holding Corp. entered into an agreement with a pharmacy benefit manager to provide coverage for TONMYA to approximately 9 million Medicare Part D plan beneficiaries effective January 1, 2027. This agreement expands the coverage of the company's product TONMYA from Medicaid coverage in most states to a total expected coverage of approximately 145 million individuals across government and and commercial channels. Tonix Pharmaceuticals Holding Corp. is a pharmaceutical company that develops and commercializes commercial products for various medical conditions.
